2aof: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2aof.png|left|200px]] | [[Image:2aof.png|left|200px]] | ||
{{STRUCTURE_2aof| PDB=2aof | SCENE= }} | {{STRUCTURE_2aof| PDB=2aof | SCENE= }} | ||
===Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6=== | ===Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6=== | ||
{{ABSTRACT_PUBMED_16218957}} | {{ABSTRACT_PUBMED_16218957}} | ||
==About this Structure== | ==About this Structure== | ||
[[2aof]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2AOF OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016218957</ref><references group="xtra"/> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| Line 37: | Line 25: | ||
[[Category: Dimer]] | [[Category: Dimer]] | ||
[[Category: Hiv-1 protease]] | [[Category: Hiv-1 protease]] | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Mutant]] | [[Category: Mutant]] | ||
[[Category: Substrate analog]] | [[Category: Substrate analog]] | ||
Revision as of 12:55, 6 January 2013
Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6
Template:ABSTRACT PUBMED 16218957
About this StructureAbout this Structure
2aof is a 3 chain structure with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Tie Y, Boross PI, Wang YF, Gaddis L, Liu F, Chen X, Tozser J, Harrison RW, Weber IT. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs. FEBS J. 2005 Oct;272(20):5265-77. PMID:16218957 doi:10.1111/j.1742-4658.2005.04923.x